.abstract img { width:300px !important; height:auto; display:block; text-align:center; margin-top:10px } .abstract { overflow-x:scroll } .abstract table { width:100%; display:block; border:hidden; border-collapse: collapse; margin-top:10px } .abstract td, th { border-top: 1px solid #ddd; padding: 4px 8px; } .abstract tbody tr:nth-child(even) td { background-color: #efefef; } .abstract a { overflow-wrap: break-word; word-wrap: break-word; }
A2817 - Burden of Cardiopulmonary Diseases and Lung Cancer Due to PM2.5 Exposure in 11 Polish Agglomerations in 2006-2015
Author Block: A. Badyda1, P. Dabrowiecki2; 1Department of Informatics and Environment Quality Research, Warsaw University of Technology, Warsaw, Poland, 2Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, Warsaw, Poland.
Objective: 75% of Europeans live in cities. The European Environment Agency estimates that exposure to concentrations of PM10 and PM2.5 above the limit values in cities of the EU concerns 8-21% of the population (and 50-91%, when taking into account the WHO guidelines).
Materials and methods: Data from the Polish State Environmental Monitoring on concentrations of PM2.5 and PM10 in 11 urban areas (with over 250,000 inhabitants) from a 10 year period (2006-2015) and data on mortality due to lung cancer, cardiopulmonary diseases, and on total non-violent mortality has been used. Using the exposure-response functions defined by Pope et al., JAMA 2002; 287:1132-1141 and Krewski et al., HEI 2009 (research report) the environmental burden of diseases attributable to exposure to ambient PM pollution has been assessed.
Results: In the analyzed period the annual mean concentration of PM2.5 exceeded the EU limit value in 9 (out of 11) cities in at least one air quality monitoring station. The WHO recommended concentration of PM2.5 was exceeded in all of the analyzed cities (also in all monitoring stations) during the whole period. Due to the relatively high concentrations of PM in Polish cities (one of the highest in the EU) population attributable fraction (PAF) is also relatively high. Average PAF varied depending on the year and city from 0.10 to 0.53 for mortality due to lung cancer, from 0.15 to 0.68 for ischemic heart disease (IHD) and from 0.07 to 0.39 for all cardiopulmonary diseases. The number of yearly mortality that could be attributed to PM2.5 varied from 24 to 438 for lung cancer and from 116 to 2093 for cardiopulmonary diseases (including 51 to 1186 cases of IHD).
Conclusion: A significant part of Polish cities population is exposed to concentrations exceeding the allowable PM level. This results in persistently high and even increasing rates of people dying from lung cancer and cardiopulmonary diseases due to the poor air quality.